Free Trial

Haleon (LON:HLN) Trading Up 0.4% - Here's Why

Haleon logo with Medical background

Shares of Haleon plc (LON:HLN - Get Free Report) rose 0.4% during mid-day trading on Friday . The stock traded as high as GBX 383.50 ($4.84) and last traded at GBX 381.97 ($4.82). Approximately 19,355,100 shares changed hands during mid-day trading, a decline of 1% from the average daily volume of 19,493,533 shares. The stock had previously closed at GBX 380.60 ($4.80).

Haleon Stock Performance

The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93. The stock has a fifty day simple moving average of GBX 374.30 and a two-hundred day simple moving average of GBX 362.40. The firm has a market capitalization of £34.53 billion, a P/E ratio of 3,183.08, a P/E/G ratio of 1.49 and a beta of 0.19.

Insider Buying and Selling at Haleon

In other Haleon news, insider Dawn Allen sold 74,679 shares of the business's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.70), for a total value of £277,805.88 ($350,632.18). Also, insider Alan Stewart acquired 33,923 shares of the firm's stock in a transaction that occurred on Wednesday, November 6th. The stock was purchased at an average cost of GBX 368 ($4.64) per share, with a total value of £124,836.64 ($157,562.34). Insiders own 10.74% of the company's stock.

Haleon Company Profile

(Get Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Read More

Should you invest $1,000 in Haleon right now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines